Quick Answer
Replimune Group, Inc. reported Diluted EPS of $3.07 per share (loss) for fiscal year 2025.
Replimune Group, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$3.07 | +5.2% |
| 2024 | -$3.24 | -8.4% |
| 2023 | -$2.99 | -32.3% |
| 2022 | -$2.26 | -29.1% |
| 2021 | -$1.75 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.77 | +2.5% | +14.4% |
| September 30, 2025 | -$0.90 | -32.4% | +5.3% |
| June 30, 2025 | -$0.95 | -21.8% | -20.3% |
| December 31, 2024 | -$0.79 | -2.6% | -16.2% |
| September 30, 2024 | -$0.68 | +24.4% | +12.8% |
| June 30, 2024 | -$0.78 | -4.0% | -1.3% |
| December 31, 2023 | -$0.77 | -11.6% | +14.4% |
| September 30, 2023 | -$0.90 | -13.9% | -20.0% |
- Replimune Group, Inc. showed an increase of +5.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Replimune Group, Inc.’s diluted eps has declined by 75.4% (from $1.75 per share (loss) to $3.07 per share (loss)).
- The most recent figure is from Replimune Group, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: